相关实验视频

Updated: May 10, 2025

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

新型双功能抗菌,通过共价结合策略的介导,通过双重目标对抗重点的多药耐药格拉姆阴性病原体

Yanan Li¹, Haoran Mei², Yuanzhen Dong^2,3

¹Department of Biological Medicines & Shanghai Engineering Research Centre of Immunotherapeutics, School of Pharmacy, Fudan University, 201203, Shanghai, China.

The Journal of antibiotics

|April 24, 2025

概括

新型双功能抗菌抗击多药耐药格兰氏阴性细菌,包括多素耐药菌株. 这些药物表现出协同效果和降低耐药性风险,为抗菌药物开发提供了一个有希望的新方法.

科学领域:

微生物学微生物学
药物发现药物发现药物发现
生物化学生物化学

背景情况:

格拉姆阴性细菌的抗生素耐药性构成了重大的临床挑战.
聚米辛耐药性是一个越来越令人担忧的问题,限制了治疗选择.
单一作用抗生素容易迅速发展耐药性.

研究的目的:

开发新的双功能抗菌.
为了解决对现有抗生素,包括多菌素的耐药性.
创建具有协同效果和降低抗性潜力的药物.

主要方法:

经过修改的PbgA衍生与使用链接器 (KCM02) 的胆固醇类型 (PE-2C-C8-DH) 的共价结合.
优化结构-活性关系以识别化合物 (BP-28和BP-37).
评估抗菌疗效,耐药性发展,毒性和目标识别 (LPS和BAMA).

主要成果:

双功能表现出协同作用的"1+1>2"疗效,对抗多药耐药的格拉姆阴性细菌,包括多素耐药菌株.
优化化合物BP-28和BP-37显示出快速杀菌活性,耐药性风险明显降低.
这些化合物没有表现出血溶性毒性或细胞毒性,并且向细菌膜成分LPS和Bamma.

结论:

开发的双功能提供了一个强有力的策略来对抗具有挑战性的阴性细菌感染.
这种方法为设计具有增强疗效和降低耐药性的新型抗菌剂提供了一个可参考的模型.
针对LPS和Bamma都是对抗细菌感染的可行机制.

更多相关视频

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Antimicrobial Peptides Produced by Selective Pressure Incorporation of Non-canonical Amino Acids

Published on: May 4, 2018

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

Published on: August 11, 2018

相关概念视频

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Antimicrobial Proteins

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

Antibiotic Selection

Antibiotic Selection